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Abstract: For many years, acetylcholine has been known to contribute to the
control of breathing and sleep. To probe further the contributions of
cholinergic rostral pontine systems in control of breathing, we designed this
study to test the hypothesis that microdialysis (MD) of the muscarinic
receptor antagonist atropine into the pontine respiratory group (PRG) would
decrease breathing more in animals while awake than while in NREM sleep. In
16 goats, cannulas were bilaterally implanted into rostral pontine tegmental
nuclei (n = 3), the lateral (n = 3) or medial (n = 4) parabrachial nuclei, or the
Kölliker-Fuse nucleus (KFN; n = 6). After >2 wk of recovery from surgery, the
goats were studied during a 45-min period of MD with mock cerebrospinal
fluid (mCSF), followed by at least 30 min of recovery and a second 45-min
period of MD with atropine. Unilateral and bilateral MD studies were
completed during the day and at night. MD of atropine into the KFN at night
decreased pulmonary ventilation and breathing frequency and increased
inspiratory and expiratory time by 12–14% during both wakefulness and
NREM sleep. However, during daytime studies, MD of atropine into the KFN
had no effect on these variables. Unilateral and bilateral nighttime MD of
atropine into the KFN increased levels of NREM sleep by 63 and 365%,
respectively. MD during the day or at night into the other three pontine sites
had minimal effects on any variable studied. Finally, compared with MD of
mCSF, bilateral MD of atropine decreased levels of acetylcholine and choline
in the effluent dialysis fluid. Our data support the concept that the KFN is a
significant contributor to cholinergically modulated control of breathing and
sleep.
Keywords: non-rapid eye movement sleep, pons
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For many years, acetylcholine (ACh) has been known to play a
role in the control of breathing14 and sleep.3 In the medial pontine
reticular formation (mPRF), endogenous ACh release causes statedependent changes in respiratory control2 and can stimulate rapid eye
movement (REM) sleep.22 Microadministration of the cholinergic
agonists carbachol (mixed cholinergic agonist), bethanechol
(muscarinic agonist), and neostigmine (acetylcholine esterase
inhibitor) into the mPRF are all known to generate this effect,1,2,18,22,27
whereas the muscarinic antagonist atropine can block this effect.1
Indeed, mPRF cholinoceptive mechanisms can cause state-dependent
changes in the firing rates of respiratory neurons in the parabrachial
nuclei.16 These studies provide evidence of anatomic connectivity from
the mPRF to the pontine respiratory group (PRG). Evidence of
projections in the reverse direction, from the PRG to the mPRF, is
provided by microinjection of fluorescent dyes into the PRG, resulting
in ipsi- and contralateral positive regions in the mPRF as well as in the
dorsal respiratory group and ventral respiratory group in the
medulla.20 However, studies of the connectivity between brain stem
respiratory neurons performed using chronically implanted arrays of
microelectrodes emphasized “a sparse distribution of functional
connections,” which suggests that interactions between brain stem
neurons include less direct pathways.29,32
Through interactions between brain stem respiratory neurons,
PRG neurons contribute not only to respiratory phase switching7,10,11,36
but also to multiple aspects of ventilatory control, including a
postulated critical role in dampening respiratory instabilities during
sleep.7,14,16,20,24 Many of the concepts regarding the role of cholinergic
modulation of breathing during sleep are based on studies during REM
sleep induced by cholinergic mimetics. These studies have led to the
hypothesis that “central cholinergic neurotransmission in reticular
regions known to generate REM sleep can contribute to statedependent respiratory depression”.22 However, there have been
relatively few studies on the contribution of cholinergic modulation to
the changes in breathing and respiratory muscle activity between
wakefulness and NREM sleep. Accordingly, the primary aim of the
present study was to determine the effects on breathing and
respiratory muscle activity during wakefulness and spontaneous NREM
sleep of reverse microdialysis (MD) of atropine into PRG subnuclei.
PRG neuronal activity is lower during NREM sleep than during
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wakefulness,16,30,33 and since this change could be due to reduced
mPRF cholinergic modulation during NREM sleep, we reasoned that
muscarinic receptor activity in the PRG would be greater during
wakefulness than during NREM sleep. The major effect of ACh receptor
activation is excitation of respiratory neurons;5,6,34 thus the
administration of the ACh antagonist atropine should decrease
excitation more during wakefulness than during NREM sleep.
Accordingly, we hypothesized that MD of atropine into the PRG would
depress breathing more during wakefulness than during NREM sleep.

Methods
For our studies, we used adult goats because their large size
permitted chronic implantation of stainless steel cannulas into the
brain stem, enabling MD of target sites. Furthermore, the status of
ventilatory parameters in goats has been well documented in our
laboratory from previous studies in the medulla and cerebellum.
Physiological data were acquired from 16 female adult goats weighing
46.4 ± 1.9 kg. Six additional goats were used for histological purposes
only (44.1 ± 2.9 kg). Goats were housed and studied in an
environmental chamber with a fixed ambient temperature and
photoperiod. All goats were allowed free access to hay and water,
except during periods of study, for which they were trained to stand
comfortably in a stanchion. All aspects of the study were reviewed and
approved by the Medical College of Wisconsin Animal Care Committee
before the studies were initiated.

Surgical procedures.
Animals were anesthetized with a mixture of ketamine and
xylazine (15 and 1.25 mg/kg, respectively), intubated, and
mechanically ventilated with 2.5% isoflurane in 100% oxygen. All
surgeries were performed under sterile conditions. A preparatory
surgery was first performed in which a 5-cm segment of each carotid
artery was isolated from the vagus and elevated subcutaneously to
facilitate future placement of chronic catheters for sampling and
monitoring. Bipolar electromyographic (EMG) electrodes were
implanted into the genioglossus, thyroid arytenoid, posterior
cricoarytenoid, and thyropharyngeus muscles through an anterior
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midline incision in the neck and were exteriorized through the skin.
EMG electrodes were also implanted in duplicate into both the
diaphragm and abdominal muscles. These EMG electrodes allowed
recording of upper airway and pump muscles activities for assessment
of respiratory rhythm and pattern as well as for detection of swallows.
For monitoring and scoring of sleep state, electroencephalographic
(EEG) and electrooculographic (EOG) electrodes were implanted in the
midline cranium and superior orbital ridge, respectively. Ceftiofur
sodium (Naxcel; 4 mg/kg im) was administered once daily (QD) for 1
wk postoperatively to minimize infection. Buprenorphine hydrochloride
(Buprenex; 0.005 mg/kg im) was administered twice daily (BID) for 2
days to mitigate pain.
After ≥3 wk, a second surgery was performed to chronically
implant stainless steel unilateral or bilateral cannulas (70-mm length,
1.27-mm outer diameter, 0.84-mm inner diameter) into multiple sites
within the rostral pons. On full recovery, the cannulas were used for
focal microadministration of atropine to target brain areas. An occipital
craniotomy was created through a posterior midline incision, and the
dura mater was excised to expose the posterior cerebellum and
medulla for visualization of obex. To standardize stereotaxic
coordinates, the orientation of the dorsal medullary surface, obex, and
midline were used to determine the dorsoventral, rostrocaudal, and
mediolateral planes, respectively. In our first few animals, cannulas
were implanted perpendicular to the brain stem, rostral to the
transverse sinuses, lateral to the superior sagittal sinus, and through
the rostral cerebellum. The tip of the cannula in these animals was
rostral to the PRG in pontine tegmental nuclei, but these animals were
useful in providing anatomical controls to our PRG-implanted animals.
To target the PRG in general and to target specific subnuclei within the
PRG, an “angled” approach was adopted. Cannulas were inserted
caudal to the confluences of sinuses, through the midcerebellum, at
angles of 10.5–24° from normal (relative to the dorsal medullary
surface), depending on the desired rostrocaudal coordinates. Given the
subnucleus of choice, cannula implantation coordinates were adjusted
within a range of coordinates: 0–2 mm ventral, 4–5 mm lateral, and
20–24 mm rostral to respective reference points. Using different
coordinates in this way, we implanted cannulas at different sites within
the PRG in 13 individual animals. After placement, cannulas were
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anchored to the surrounding bone using screws and dental acrylic, and
a stainless steel stylet was inserted to maintain patency.
Experienced laboratory personnel continuously monitored the
goats (for at least 24 h) after brain surgery until stable conditions
were achieved. Buprenorphine was administered for pain as previously
explained. Chloroamphenicol (20 mg/kg iv) was administered three
times daily (TID) for 3 days to minimize infection, as was
dexamethasone (0.4 mg/kg decreasing to 0.05 mg/kg iv, TID) for 7
days to minimize swelling. Thereafter, until death, centiofur sodium
and gentamycin (Gentamax 100; 6 mg/kg im, QD) were administered.

Physiological measurements.
Studies commenced ≥2 wk after the brain surgery. For all
studies, a custom-fitted mask was secured to the goat's muzzle, with a
two-way breathing valve attached to the mask. A pneumotach was
attached in series with the inspiratory side to measure flow via a
Windaq computer data acquisition system. A spirometer was
connected to the expiratory side, allowing determination of expired
volume and concentrations of CO2 and O2 to calculate metabolic rate. A
chronically placed catheter in the elevated carotid artery was used to
continuously record arterial blood pressure and heart rate and for
collection of blood samples to obtain arterial pH (pHa), Pco2 (PaCO2),
and Po2 values (PaO2). Body temperature was measured rectally at
regular intervals.

In vivo microdialysis.
The MD probes (CMA Microdialysis, Solna, Sweden) were 72 mm
(70-mm shaft and 2-mm membrane) in total length and were inserted
through the stainless steel cannula such that only the membrane (0.5mm diameter, 20-kDa molecular mass cutoff) penetrated the brain
tissue. The probes were secured in place before the study began and
remained there for the duration of the protocol. The dialysate was
mock cerebrospinal fluid (mCSF: 124 mM NaCl, 2.0 mM KCl, 2.0 mM
MgCl2, 1.3 mM K2PO4, 2.0 mM CaCl2, 11 mM glucose, and 26 mM
NaHCO3 in sterile distilled H2O) with or without atropine. In a
tonometer, this solution was heated to 39°C and equilibrated with a
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physiological gas mixture (6.4% CO2-21% O2-balance N2). MD probes
were double-barreled, allowing delivery and, in a subset, collection of
the dialysate. Affluent dialysate was delivered (50 μl/min) using a
syringe pump, and in a subset, effluent dialysate was collected in
modified Eppendorf tubes for subsequent content analysis using liquid
chromatography-electrochemistry (LC-EC). The syringes containing
mCSF or atropine were connected to the MD probes by 150 cm of
polypropylene microtubing, allowing isolation of the animal away from
the syringe pump and associated activities.
The study protocol consisted of a 30-min control period followed
by a 45-min period of MD (50 μl/min) with mCSF, a 30-min recovery
period, a second 45-min period of MD with atropine (50 mM in mCSF),
and, finally, another 30 min of recovery. The atropine concentration,
flow rate, and dialysis period of 45 min were chosen because in in vitro
studies, these parameters were sufficient for delivery of atropine
across the membrane of the probe (Table 1). The duration of the
recovery period was chosen because in initial studies, any effects of
MD had usually been alleviated by 30 min after MD was terminated.
Thus total study duration was ≥3 h. Of note, the first 7–8 min of the
second period of MD with atropine actually included delivery of the
mCSF, which remained in the polypropylene microtubing from the first
MD period. Thus any effects observed within the first 7–8 min of the
second MD period could not be due to atropine. Arterial blood was
sampled over the last 5 min of control, MD, and recovery periods and
analyzed for PaO2 (Torr), PaCO2 (Torr), and pHa (pH units) (model 248;
Bayer Diagnostics).
Table 1. Differences in ACh and choline concentrations in response to
microdialysis of mCSF and atropine in KFN, MPBN, and LPBN
Difference in Concentration, μM/ml
ACh

Mean ± SE

Choline

Unilateral

Bilateral

Unilateral

Bilateral
−0.43 ± 0.19

0.18 ± 0.17

−0.63 ± 0.20

0.01 ± 0.11

t-test P value

0.929

0.027

0.936

0.053

KFN

−0.12

−1.3

−0.28

−0.04

−0.25

−0.53

−0.16

−0.09

+0.37

−0.08

−0.28

+0.12

−0.15

+0.05

+0.81

−0.06

−1.41

+0.01
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Difference in Concentration, μM/ml
ACh
Unilateral

Choline
Bilateral

Unilateral

Bilateral

−0.09
−0.05
0
−0.19
−0.17
−0.73
MPBN

−0.21

−1.22

−0.11

−1.18

+0.11

−0.1

−0.06

−0.31

+0.04

−2.26

−0.47

−0.17

−0.03

−0.25

−0.27

−0.04

−0.31

−2.24

0.00

−0.06

−0.35

0.00
−0.62
LPBN

+1.14

−0.01

+1.36

−0.04

+1.07

−0.59

+1.35

−1.09

+0.02

−0.62

+0.01

−0.44

Compared with bilateral microdialysis (MD) of mock cerebral spinal fluid (mCSF),
bilateral MD of atropine significantly (P < 0.05) decreased the concentrations of both
ACh and choline in the effluent dialysis fluid. Unilateral MD of atropine did not
significantly (P > 0.05) affect ACh or choline concentration in the effluent dialysis fluid.
Each value (mean ± SE) is the difference in concentration of ACh or choline between
MD of mCSF and atropine. Data were obtained during MD into the Kölliker-Fuse
nucleus (KFN) and the lateral (LPBN) and medial parabrachial nuclei (MPBN). Values in
bold type were obtained from studies at night, and the remainder were obtained from
studies during the day. We were unable to obtain separate values at night for awake
and non-rapid eye movement (NREM) sleep states.

MD studies were conducted on six separate days, three during
the day (9:00 AM to noon) and three during the night (10:00 PM to
1:00 AM). The studies at night directly tested the hypothesis regarding
a state-dependent role of pontine cholinergic modulation of breathing.
The studies during the day provide information on whether pontine
cholinergic modulation is a determinant of breathing while goats are
awake during the day and to explore possible circadian influences on
the cholinergic system. Studies were never completed on consecutive
days, and studies were separated by at least 36 h. The six MD studies
consisted of four unilateral studies (left and right cannulas during the
day and night) and two bilateral studies (bilateral cannulas during the
day and night). The sequence of the four unilateral studies was
randomly determined, as was the sequence of the two bilateral
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studies. Because we were unsure whether there would be a carryover
effect of atropine or an effect of inserting the dialysis probe, the
unilateral studies were always completed before the bilateral studies;
thus, at each unilateral site, the data obtained were not complicated
by previous dialysis. For daytime studies, animals were loosely tied in
a stanchion so that they could not assume sternal recumbency, which
is the preferred sleep posture for goats. For studies conducted at
night, goats were not allowed to assume sternal recumbency between
4:00 PM and 10:00 PM in an effort to consolidate sleep. However,
goats were still permitted free access to food and water during this
time. At 10:00 PM, when the nighttime study commenced, ties were
removed so that the goat could assume sternal recumbency within the
stanchion. All connections to the animal were adjusted to
accommodate this increased range of motion.

In vitro microdialysis.
To confirm delivery of atropine across the MD probe membrane,
an Eppendorf tube (reservoir) was filled with either 0.6 or 1.5 μl of
mCSF. A stainless steel cannula was passed through a hole bored in
the reservoir cap. A MD probe was inserted through the cannula into
the reservoir, and all connections were sealed with silicon gel. Atropine
(50 mM) in mCSF was dialyzed for 45 min. Subsequently, the reservoir
atropine concentration was determined using liquid chromatographymass spectrometry (LC-MS).

Data and statistical analyses.
Pulmonary ventilation (V̇i; l/min), breathing frequency (f;
breaths/min), tidal volume (Vt; l/min), expiratory (Te; s) and
inspiratory times (Ti, s), respiratory muscle activity (mV), and, in
addition for night studies, EEG and EOG activities were analyzed on a
breath-by-breath basis. First, the blood pressure and airflow signals
were calibrated against known values, whereas EMG signals were
zeroed at the baseline. The calibrated signals were rectified and time
averaged. During the experimental control periods, these rectified and
time-averaged signals were used to recalibrate the EMG signals with
the assignment of arbitrary peak (1) and baseline values (0). These
recalibrated EMG signals were again rectified and time averaged. This
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recalibration and further processing of the EMG signals was necessary
because of the absence of known values and provided a measure of
relative magnitude within studies. Finally, the signals were converted
to a .txt file and input into a custom-designed program that output all
parameters on a breath-by-breath basis.
The EEG and EOG activities were used to visually distinguish
between states of consciousness. Wakefulness was characterized by a
high-frequency, low-voltage EEG, with variable EOG activity. Non-rapid
eye movement (NREM) sleep was characterized by a low-frequency
(<2 Hz), high-voltage (2–3 times greater than that found in
wakefulness) EEG, with absent EOG activity. REM sleep was
characterized by a high-frequency, low-voltage EEG, similar to
wakefulness but concurrent with frequent and distinct bursting activity
(>30 μV) in the EOG. For night studies, each breath was categorized
as awake, NREM sleep, or REM sleep. The breaths were then further
categorized as “quiet,” regular breaths or those that were
“irregular/disrupted,” characterized by any respiratory muscle activity
that was inappropriate, including swallowing, coughing, mastication,
and eructation, as well as any abnormal patterns that could not be
identified as a specific behavior. The rationale for this second
categorization was as stated by Bolser et al.:8 “the presence of
elements that are normally silent in close proximity to spontaneously
active respiratory neurons raises the possibility that some
interventions that are intended to study the neurogenesis of breathing
might instead be influencing components of the holarchical system
that are only conditionally active;” thus it was essential to make a
delineation between the two types of breaths (nondisrupted vs.
disrupted). The data reported are for periods of nondisrupted
breathing.
Breath-by-breath values were averaged into 15-min bins and
expressed in either their raw form or as a percentage of the bins in the
control period. The 15-min bin values for the two unilateral studies on
each goat were averaged, and statistical analyses of the unilateral
data were performed using the averaged values. One-way analysis of
variance (ANOVA) was used on all ventilatory variables for control
periods to determine whether there were chronic changes as a result
of cannula implantation and/or the series of MD studies. Tukey's post
hoc test was used to identify specific changes. To test whether the
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measured variables (expressed as a percentage of control) changed
over the 180 min of the MD protocol and whether there were
differences between goats with different sites of cannula implantation,
a two-way ANOVA (time and site as factors) was used. If the ANOVA
was significant, then Tukey's post hoc analysis was used to determine
which values during dialysis and recovery differed from the control
period. This analysis was completed for MD studies while goats were
awake during the day and also for MD studies at night during the
awake and NREM sleep states. These analyses were performed for
both the unilateral and bilateral data.
The breath-to-breath coefficient of variation (CV) (SD/mean ×
100) was also calculated for each 15-min bin for all ventilatory
variables, and ANOVA and Tukey's test were used to establish
statistical significance. For night studies, respective states are reported
as a percentage of the total time per 15-min bin, and ANOVA and
Tukey's test were used to determine whether the percentage of time in
NREM sleep changed over the 180 min and whether there were
differences between the groups. There was insufficient data during
REM sleep for statistical analysis. The number of apneas (apnea Te ≥
2.5 × average Te) and augmented breaths (augmented breath Vt ≥
2.5 × average Vt) were tabulated for each 15-min bin. Apneas
following augmented breaths were not included in the apnea analyses.
ANOVA and Tukey's test were used to determine whether the number
of apneas and augmented breaths changed over the 180-min protocol
and whether there were group differences. To test whether levels of
ACh and choline were significantly (P < 0.05) different between mCSF
and atropine MD, a paired t-test was performed on effluent dialysate
LC-EC raw values.

Histological analyses.
After completion of this experimental protocol, in all but one
goat, we injected ibotenic acid (IA) into the PRG to determine the
ventilatory effects of neurotoxic lesions (data not reported). One week
after the last IA injection, the goats were euthanized (Beuthansia;
intravenously), and the brain was perfused with physiological buffer
solution (PBS) and fixed with 4% paraformaldehyde (PFA) in PBS. The
brain stem was excised and placed in 4% PFA in PBS for 24 h and then
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in 20 and 30% sucrose solutions, sequentially. The brain stem was
frozen and serially sectioned (25 μm) from obex to the superior
colliculi in a transverse (n = 21) or sagittal (n = 1) plane, and the
sections were adhered to gelatin-chrome-alum-coated slides. Sections
were acquired such that every fourth section was contained within a
respective “series.” Thus there were four series in total; within a
series, each section was 100 μm from the next section in sequence,
allowing for high-resolution neuronal and anatomical profiling. One
series was stained for Nissl substance to profile the total number of
neurons. A second series was stained for muscarinic type-2 (M2)
immunoreactivity by complexing anti-M2 receptor primary antibody
(Millipore; 1:200 dilution) with biotinylated anti-mouse secondary
antibody (Vector; 1:100 dilution). After the antibody-antigen complex
was incubated, it was localized by avidin (Vector ABC Elite) and
developed with diaminobenzene. The three PRG nuclei heavily stain for
the M2 receptor in contrast to an absence of staining in the superior
cerebellar peduncle; thus this series was used to identify the area of
the lateral (LPBN) and medial parabrachial nuclei (MPBN) and KFN.
The third and fourth sections in each series were used for purposes
unrelated to this report.
Since the 2 mm of the MD probe membrane were inserted 2 mm
beyond the tip of the cannula, the major effect of MD would be on
neurons 2 mm distal to the tract created by the cannula. Thus the
goats were grouped according to identification of the distal end of the
cannula tract visualized on the Nissl- and M2-stained sections.
Accordingly, there were three, four, six, and three goats in the LPBN,
MPBN, KFN, and rostral pontine tegmental nuclei (RPTN) groups,
respectively.
The Nissl- and M2-stained sections in the control goats were
used to establish the morphology of the LPBN, MPBN, and KFN. The
nuclei were identified as described above, and then the Nissl-stained
sections were used to manually count the total number of neurons and
determine the area of each subnucleus (Metamorph software and
standardized procedures).

Journal of Applied Physiology, Vol 109, No. 1 (July 2010): pg. 159-170. DOI. This article is © American Physiological Society
and permission has been granted for this version to appear in e-Publications@Marquette. American Physiological Society
does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express
permission from American Physiological Society.

12

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Results
Histology and cannula placement.
Figure 1, A and B, shows Nissl-stained sagittal and transverse
sections as well as sections immunostained for the M2 receptor. The
extensive M2 staining is consistent with a potential role of cholinergic
modulation in the role of the rostral pons in the control of breathing.25
As shown by these sections and the schematic in Fig. 1B, the LPBN
and MPBN flank the superior cerebellar peduncle (SCP), and the KFN
extends ventral and lateral to the LPBN and MPBN. As shown in Fig. 2,
A and B, in goats, the morphology of the LPBN and MPBN is quite
different from that of the KFN. The KFN is quite confined, spanning
only 2–3 mm rostrocaudally, whereas the LPBN and MPBN are more
widespread, spanning a rostrocaudal distance of 6–8 mm, and are thus
larger areas and include more neurons than the KFN (Fig. 2B).
Accordingly, we presume that MD of atropine in the KFN likely
attenuated muscarinic activity of a larger percentage of total KFN
neurons than when atropine was MD in the LPBN and MPBN.

Fig. 1. Histochemical and immunohistochemical staining for Nissl substance and
muscarinic type-2 (M2) receptors provides anatomic characterization of the pontine
respiratory group in goats. A: sagittal sections (from a control goat) 4.9 mm lateral to
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the midline show the location in the rostral, dorsal pons of the lateral (LPBN) and
medial parabrachial nuclei (MPBN) and the Kölliker-Fuse nucleus (KFN) relative to the
cerebellar peduncle (SCP). B: transverse Nissl- and M2-stained sections from another
control goat and a schematic to further illustrate the location of the LPBN, MPBN, and
KFN. The superior and inferior colliculus (IC), trigeminal motor nucleus,5 basal pons
(BP), facial nucleus,7 and nucleus ambiguus (NA) are labeled for reference. D, dorsal;
V, ventral; R, rostral; C, caudal; M, medial; L, lateral.

Fig. 2. In the rostrocaudal direction of control goats, there are changes in the
anatomy of the LPBN, MPBN, and KFN. A: immunohistochemically stained
hemisections for the M2 receptors of a control goat and a schematic illustrating the
location of the LPBN, MPBN, and KFN at 7 different rostrocaudal distances from the
peak (pKFN) number of neurons in the KFN. B: plots of the number of neurons in the
LPBN, MPBN, and KFN of control goats at different rostrocaudal distances relative to
the pKFN. Among the 3 subnuclei, note the differences in number of neurons
rostrocaudally. Filled symbols indicate unilateral neuron counts from individual goats;
open symbols indicate the mean of all control goats.

Verification of MD efficacy.
In vitro dialysis confirmed that atropine moved across the probe
membrane. The concentration of atropine in the mCSF within the
reservoir was 76 and 97 μM for reservoir volumes of 1,500 and 600 μl,
respectively.
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We did not measure atropine in PRG tissue during in vivo MD,
but indirect evidence of a significant movement of atropine into the
tissue was provided by the finding that bilateral MD of atropine
decreased ACh and choline levels in the MD effluent fluid. Limited data
were obtained for each PRG site, but in three of four KFN sites, four of
four MPBN sites, and three of three LPBN sites, there was less ACh in
the effluent sample after MD of atropine than after MD of mCSF (Table
1). The same consistent decrease was found in effluent choline
concentration. Pooling the data yielded a mean difference for ACh of
−0.63 ± 0.2 μM/ml (P < 0.027) and for choline of −0.043 ± 0.19
μM/ml (P < 0.053). During unilateral MD, there was no significant
difference in either ACh or choline concentration between mCSF and
atropine MD (Table 1).

Breathing.
V̇i was significantly (P < 0.05) reduced 2 wk after implantation
of the cannulas compared with preimplantation studies (Table 2).
These decreases were due primarily to a reduction in Vt (Table 2) and
were secondary to a reduction in metabolic rate (data not shown).
Breathing frequency and arterial blood gases were not altered by
implanting the cannulas (Table 2). There were no significant (P <
0.05) changes in any ventilatory variable between the control periods
before the MD studies were initiated and a control period after the final
MD study; thus there was no apparent chronic effect of atropine MD on
eupneic breathing.
Table 2. Effects of cannula placement on physiological parameters
V̇i, l/min

f, breaths/min Vt, l/breath PaCO2, Torr

PaO2, Torr

RPTN
Preimplant

7.60 ± 0.98

20.68 ± 2.83

0.40 ± 0.02

39.1 ± 1.0

97 ± 5

Postimplant

6.47 ± 0.67

*

19.46 ± 2.06

0.38 ± 0.03

*

39.8 ± 1.6

91 ± 6

Post-Atr MD

6.48 ± 0.23*

21.34 ± 1.98

0.36 ± 0.02*

40.1 ± 1.7

97 ± 5

Preimplant

8.59 ± 1.25

16.56 ± 0.60

0.53 ± 0.07

39.6 ± 0.4

104 ± 11

Postimplant

6.76 ± 1.18*

19.77 ± 1.60

0.38 ± 0.07*

40.3 ± 1.5

92 ± 11

Post-Atr MD

6.67 ± 0.30

17.85 ± 1.72

0.42 ± 0.04

41.3 ± 0.7

97 ± 3

Preimplant

6.27 ± 0.43

16.47 ± 0.90

0.40 ± 0.04

41.6 ± 0.7

101 ± 4

Postimplant

6.39 ± 0.60

18.63 ± 1.46

0.35 ± 0.02*

43.1 ± 1.8

92 ± 6

Post-Atr MD

6.31 ± 0.58

19.11 ± 0.98

0.34 ± 0.02*

43.8 ± 1.8

102 ± 6

LPBN

*

*

MPBN

KFN
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V̇i, l/min

f, breaths/min Vt, l/breath PaCO2, Torr

PaO2, Torr

Preimplant

7.79 ± 0.78

17.84 ± 1.16

0.46 ± 0.04

41.2 ± 0.7

97 ± 4

Postimplant

6.77 ± 0.30*

17.93 ± 1.06

0.40 ± 0.02*

39.7 ± 0.4

92 ± 2

Post-Atr MD

6.85 ± 0.36

16.16 ± 1.23

0.47 ± 0.04

39.9 ± 0.6

101 ± 3

*

After implantation of the cannula, pulmonary ventilation (V̇i) was significantly reduced
from preimplantation studies, and these effects were generally due to a reduction in
tidal volume (Vt).
*P < 0.05, significant differences from preimplantation studies. Breathing frequency (f)
and arterial blood gases (PaCO2, PaO2) were not significantly (P > 0.05) changed by
implantation of the cannula.

As shown in Fig. 3 for four different individual goats, during MD
into three of the four rostral pontine sites, V̇i was stable throughout
the 3 h of the daytime and nighttime studies. Indeed, neither
unilateral nor bilateral MD of either mCSF or atropine during daytime
studies significantly (P < 0.05) affected V̇i, f, Ti, or Vi regardless of
cannula site (Fig. 4). However, in goats with unilateral daytime MD of
atropine into the LPBN, Te was increased (P < 0.05) by 19% during
the recovery period (Fig. 3).

Fig. 3. Pulmonary ventilation (V̇i) of 4 different goats during microdialysis (MD) of
mock cerebrospinal fluid (mCSF) or atropine in studies during the day in the awake
state and in studies at night during the awake and NREM sleep states. The MD was in
either the rostral pontine tegmental nucleus (RPTN) or in the LPBN, MPBN, or KFN.
Note the relatively stable V̇i throughout the protocol for all goats except that for the
nighttime studies in the KFN goat, V̇i decreased during atropine MD in both the awake
and NREM sleep states. Shaded boxes indicate periods of MD with either mCSF or
atropine.
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Fig. 4. Neither unilateral nor bilateral MD of either mCSF or atropine during daytime
studies had any significant effect on ventilatory parameters, with the exception of an
increase in expiratory time (Te) following unilateral MD of atropine into the LPBN (n =
3). Data were obtained during MD in the RPTN (n = 3), MPBN (n = 4), or KFN (n = 6).
f, Breathing frequency; Ti, inspiratory time. Shaded boxes indicate periods of MD with
either mCSF or atropine. *P < 0.05, significant differences from control.

As also shown in Fig. 3, the exception to the stable V̇i during the
MD studies was during MD of atropine into the KFN at night, when V̇i
decreased during both the awake and NREM sleep states (Fig. 3).
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Indeed, unilateral MD of atropine into the KFN during nighttime studies
significantly decreased V̇i by 14% (P < 0.001) during NREM sleep and
also, although not significantly, by 12% (P = 0.117) during
wakefulness (Fig. 5). Bilateral MD of atropine significantly decreased V̇i
by 12% during wakefulness (P < 0.01) and also by 12% during NREM
sleep, although this decrease was not statistically significant (P =
0.127) (Fig. 5). Unilateral and bilateral decreases in V̇i were due to
decreases of 13% (P < 0.001) and 12% (P < 0.001) in f, respectively,
during wakefulness and NREM sleep (Fig. 5). In unilateral studies, Ti
was increased by 18% (P < 0.05) during NREM sleep and marginally
by 13% (P = 0.059) during wakefulness, whereas Te increased 19% (P
< 0.001) during NREM sleep and 15% (P < 0.001) during wakefulness
(Fig. 5). In bilateral studies, Ti increased by 15% (P < 0.05) during
NREM sleep and 13% (P = 0.21) during wakefulness, with Te
increased by 23% (P < 0.05) during NREM sleep and 19% (P < 0.001)
during wakefulness (Fig. 5). The effects of atropine MD were in many
cases observed during recovery from MD, which probably reflects a
relatively slow washout of atropine from the tissue. There were no
significant changes in Vt (data not shown). Ventilatory data during
REM sleep are not available because there was an insufficient amount
for analysis.

Fig. 5. Unilateral and bilateral MD of atropine during nighttime studies in KFN animals
(n = 6) decreased V̇i and f and increased Ti and Te during both awake and NREM sleep
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states. There were no consistent and sustained changes in any variable during
unilateral or bilateral MD of mCSF or atropine into the RPTN (n = 3), LPBN (n = 3), or
MPBN (n = 4). Shaded boxes indicate periods of MD with either mCSF or atropine. *P
< 0.05, significant differences from control.

With two exceptions, there were no consistent and sustained
changes in any ventilatory variable during MD at night into the RPTN,
LPBN, and MPBN (Fig. 5). One exception was during unilateral MD of
mCSF at night, when V̇i decreased (P < 0.05) in MPBN goats by 18%
(Fig. 5). The second exception was in RPTN goats when unilateral MD
at night increased (P < 0.05) V̇i by 18% during recovery from MD of
mCSF (Fig. 5). These changes probably reflect effects of MD per se.
There were no significant (P < 0.05) changes in the CV of any
ventilatory variable during any study at all sites.

Sleep.
During the recovery period from bilateral MD of atropine into the KFN,
the amount of NREM sleep (Fig. 6) was increased by 365% (P < 0.01).
This increase in NREM sleep was presumably due to a stabilization of
sleep mechanisms, as evidenced by a 990% (P < 0.001) increase in
the average time per sleep epoch. During the recovery from unilateral
MD of mCSF and atropine into the KFN, the time per sleep epoch was
also significantly (P < 0.05) increased (Fig. 6). The percentage of time
in NREM sleep was not significantly (P < 0.05) altered by MD of
atropine into the RPTN, LPBN, or MPBN.

Fig. 6. During the recovery period from bilateral MD of atropine into the KFN (n = 6),
there was a significant (P < 0.05) increase in NREM sleep time and an increase the
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duration of a NREM sleep epoch. During recovery from unilateral MD of either mCSF or
atropine into the KFN, there was an increase in the duration of a NREM sleep epoch.
During MD of mCSF or atropine into the RPTN (n = 3), LPBN (n = 3), or MPBN (n = 4),
there were no significant effects of NREM sleep time or duration of NREM epoch.
Shaded boxes indicate periods of MD with either mCSF or atropine. *P < 0.05,
significant differences from control.

Respiratory muscle activity.
Compared with control levels, unilateral and bilateral MD of
atropine had no significant (P < 0.05) effect on the quantified
integrated diaphragm, abdominal, or genioglossus (GG) (Fig. 7)
muscle activity during daytime or nighttime studies. However,
beginning during the MD of mCSF and persisting through MD of
atropine, the CV for GG activity during the day was increased by 68%
(P < 0.001) in unilateral studies and by 47% (P < 0.001) in bilateral
MD into the KFN (Fig. 8). There was no significant effect of MD on the
CV for nighttime GG activity (Fig. 8). Furthermore, there was no
significant effect on the variation of diaphragm or abdominal muscle
activities. There were no data on GG activity for MD into the RPTN,
because implantation of GG electrodes was added part way through
the protocol and as such were not implanted in these initial animals.

Fig. 7. There were no significant (P > 0.05) changes in the level of genioglossus (GG)
muscle activity during MD of mCSF or atropine into the LPBN (n = 3), MPBN (n = 4),
or KFN (n = 6) during daytime or nighttime studies. Shaded boxes indicate periods of
MD with either mCSF or atropine.
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Fig. 8. The coefficient of variation (CV; SD/mean × 100) for daytime GG muscle
activity was increased during unilateral and bilateral MD of atropine into the KFN (n =
6). There was no significant effect on the CV of GG activity during MD into the KFN at
night, and there were no significant (P > 0.05) effects with MD into the LPBN (n = 3)
or MPBN (n = 4) during daytime or nighttime studies. Shaded boxes indicate periods
of MD with either mCSF or atropine. *P < 0.05, significant differences from control.

Apneas and augmented breaths.
MD into the RPTN during the day increased the mean number of
apneas per total number of breaths compared with MD into the LPBN
(P < 0.05), MPBN (P < 0.05), and KFN (P < 0.01) (data not shown).
There were no other significant (P < 0.05) effects of MD on apneas or
augmented breaths per total number of breaths during daytime or
nighttime studies.

Other physiological parameters.
There were no significant consistent effects during the day or at
night of unilateral or bilateral MD on PaCO2, PaO2, pHa, body
temperature, V̇o2, V̇co2, heart rate, or arterial blood pressure (data not
shown). All values were within normal limits for goats.
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Discussion
Summary.
The major physiological changes observed in the present study
are that unilateral and bilateral MD of atropine into the KFN at night
decreased V̇i and f and increased Ti and Te by 12–23% during both
wakefulness and NREM sleep. Our primary hypothesis regarding statedependent effects of attenuating muscarinic receptor activity in the
PRG was not validated.

Limitations.
One constraint of this study was our inability to unequivocally
define the anatomic region affected by MD of atropine. The grouping of
the goats was based on the distal-most tract created by the implanted
cannula. The MD probe was inserted 2 mm beyond the tip of the
cannula; thus the membrane for reverse MD was within the designated
area. However, atropine may have diffused beyond respective target
nuclei. Exactly how far, and to what extent, atropine diffused was
dependent on numerous factors including rate of diffusion,
metabolism, and clearance of atropine. The anatomical morphology
and tissue reaction to the cannulas and/or probes may have caused a
difference in diffusion at different PRG sites and/or differences
between goats. However, the finding that bilateral MD of atropine at
each PRG subnucleus uniformly decreased ACh and choline in the
effluent fluid compared with MD of mCSF provides indirect evidence
that atropine reached the tissue at each site (Table 1).
As shown in Fig. 2, the morphology of the LPBN and MPBN was
quite different from that of the KFN. Compared with the KFN, the LPBN
and MPBN are more widespread, larger in area, and contain more
neurons. Accordingly, it was possible to only dialyze part of the LPBN
and MPBN, whereas a relatively larger portion of the KFN was dialyzed
when targeted; thus we cannot exclude the possibility of more
prominent effects if atropine had been dialyzed into a larger portion of
or in other parts of the LPBN and MPBN. Moreover, it is possible that
the effective atropine concentration was not uniform at all PRG sites
and during all periods of dialysis. It is conceivable that repeated
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insertion of the dialysis probe destroyed neurons and/or altered
diffusion characteristics, thereby causing nonuniform delivery of
atropine. We were unable to determine for each group the potential
damage caused by dialysis, because after completion of the six dialysis
studies, in all but one goat we studied the effects of injecting the
neurotoxin ibotenic acid. In the single goat in which ibotenic acid was
not injected, the number of neurons distal to the cannula were within
the normal variation of the control goats. Thus we did not obtain any
evidence that MD per se affected the tissue within the region dialyzed.
Another limitation of the present study is the small sample size
in the LPBN, MPBN, and RTPN groups. As shown in Figs. 4 and 5, there
were trends of changes induced by MD into these areas that might
have been statistically significant if the number of goats was greater.
Indeed, the power of some of the statistical analyses was less than
0.2; thus, for groups with a low number of goats, we cannot state with
confidence whether changes indeed did or did not occur.
Because of these three limitations (uncertainty of diffusion
distance and effective tissue atropine concentration, differences in
morphology between PRG regions, and small sample size of 3 groups),
it is inappropriate to conclude that there is a site-specific effect of
atropine dialysis into the PRG. Our conclusion is that cholinergic
modulation of KFN neurons contributes to the control of breathing
during the night, but we cannot discount the possibility that cholinergic
modulation of LPBN, MPBN, and RTPN neurons may also contribute to
control of breathing.

State-dependent changes in breathing.
In most mammals, there is a decrease in breathing between
wakefulness and NREM sleep. One postulated explanation for these
changes is that the activity of serotonergic, adrenergic, and cholinergic
neurons in the brain stem decreases between wakefulness and NREM
sleep.6,27 If these are sources of excitatory neuromodulation of
respiratory neurons, then the activity of respiratory neurons will be
less during NREM sleep than during wakefulness. Indeed, it has been
shown that the activity of PRG respiratory modulated neurons is less
during NREM sleep than during wakefulness.16,30,33 Such reduced
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excitation could then contribute to the reduced breathing during NREM
sleep compared with wakefulness.
If indeed cholinergic modulation is excitatory to PRG neurons
and this excitatory effect is relatively greater during wakefulness than
during NREM sleep, it seems appropriate to hypothesize that the effect
of atropine attenuation of muscarinic activity in the PRG will be greater
during wakefulness than during NREM sleep. However, we found that
the effect of atropine MD into the KFN nearly equally reduced V̇i during
wakefulness and NREM sleep. In addition, during both states, the
reduced V̇i resulted from reduced f secondary to increased Ti and Te.
Accordingly, our data do not support the concept that lower KFN
neuronal activity and lower V̇i during NREM sleep are due to reduced
excitatory cholinergic modulation of KFN neurons during NREM sleep
relative to wakefulness.
The data from several studies have led to the conclusion that
increased ACh release into the mPRF promotes REM sleep and
depresses breathing through an effect on PRG respiratory neurons.21
We were unable to directly address this concept because of the
minimal REM sleep in these goats. Nonetheless, our data do not
provide support for the concept that there is a state-dependent effect
of cholinergic modulation of breathing by PRG neurons.

Day-night differences in effect of atropine.
Except for a significant (P < 0.05) increase in Te during
recovery from atropine MD into the LPBN, there were no other
significant (P < 0.05) effects of atropine MD during the day; thus it is
unlikely that cholinergic modulation of PRG neurons is a determinant of
breathing during wakefulness during the day. The finding that atropine
MD into the KFN depressed breathing during wakefulness at night but
not during wakefulness during the day suggests that there is possibly
a circadian component to cholinergic modulation of PRG neurons. The
present study was not ideally designed to test for a circadian
contribution to cholinergic modulation of breathing, because it would
have required control of multiple variables, including feeding routine,
standing vs. prone posture, behavior of chambermates, and visual
cues associated with chronological time; thus our data do not establish
a definitive circadian effect of cholinergic modulation. However, in
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addition to sleep-dependent changes in neuromodulators, there also
are documented circadian-dependent changes in neuromodulators. For
example, serotonin levels in the pineal gland and the suprachiasmatic
nucleus are lower in rats during the light cycle than during the dark
cycle, and this difference appears to be controlled by circadian
variation in adrenergic signaling.4,12,25,37,38 It is not known whether
there are circadian variations in PRG cholinergic, adrenergic, and
serotonin neuromodulation, but on the basis of our present findings,
coupled with documented circadian variations in breathing,28,35 further
studies are warranted on circadian variation of cholinergic modulation
of PRG neurons.

Cholinergic modulation of GG muscle activity.
The tone of the pharyngeal GG muscle is reduced during NREM
sleep, which reduces airway size and increases airway resistance, and
in some humans this results in collapse of the airway (obstructive
sleep apnea). The cause of these effects has not been established.
Since there are projections from pontine cholinergic neurons32 to the
hypoglossal nucleus, one potential contributing factor is altered
cholinergic modulations of the motoneurons in the hypoglossal
nucleus. Indeed, Kodama et al.19 found in decerebrate cats that
microinjection of ACh into the rostral pons causes GG muscle atonia
while simultaneously increasing both glycine and GABA release in the
hypoglossal nucleus. Moreover, there are documented projections from
the KFN to the hypoglossal nucleus,15,17,39 but the significance of these
projections is unknown, leading Horner17 to conclude “it remains to be
determined if modulation of central cholinergic activity importantly
contributes to changes in GG activity across sleep-wake states.”
Accordingly, we sought to determine whether attenuation of PRG
muscarinic receptor activity with MD of atropine would affect GG
muscle activity. We did not obtain any significant evidence that either
the magnitude or variability of GG muscle activity was altered by MD
of atropine into any PRG subnucleus during wakefulness and NREM
sleep. The stable and constant muscle activity occurred even though
multiple ventilatory variables were affected and NREM sleep was
promoted during atropine MD into the KFN.
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During the recovery from both unilateral and bilateral MD of
mCSF into the KFN in daytime studies, variability in GG muscle activity
began to increase, and it remained increased during and after MD of
atropine. In addition, variability in GG muscle activity overall tended to
be higher during the day than at night. Since pontine perturbations
may affect a network with complex excitatory and inhibitory
feedforward and feedback mechanisms that are postulated to
contribute to the stabilization of breathing and respiratory muscle
activity,13 it is not surprising that we found considerable variation in
activity of the GG muscle. Disruption of this stabilizing role may
contribute to sleep disordered breathing. However, the disruptions by
MD per se and by MD of atropine during wakefulness and NREM sleep
states in the present study did not cause profound destabilization
characteristic of REM sleep.

Effect of atropine MD on effluent ACh and choline and
sleep.
It seems that a logical consequence of attenuating muscarinic
receptor activity in the PRG would be a compensatory increase in
release of ACh. However, we found that MD of atropine resulted in a
decrease in ACh and choline in the effluent dialysis fluid (Table 1). We
are unable to explain this finding. However, the decrease in ACh may
have contributed to two findings. First, the decreased ACh would
seemingly have the same effect as attenuating muscarinic receptor
activity with atropine. Indeed, the decrease in breathing during MD of
atropine into the KFN could have been due to decreased ACh, rather
than a direct effect of atropine on the muscarinic receptor. Second, a
decrease in ACh also promotes NREM sleep; thus the increased
amount of NREM sleep and increased in time per NREM sleep epoch
during atropine MD into the KFN might be secondary to the decrease in
ACh.
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